Remedium Bio
Needham
About Remedium Bio
Remedium Bio is a Boston area gene therapy company focused on the development of curative treatments for a number of highly debilitating conditions. Our fundamental approach to product development utilizes proven technologies in novel ways to treat well-characterized disease pathology. To streamline R&D, we modularly apply elements of proven technology to develop local, targeted treatments focusing on clinically validated molecules and mechanistic pathways. Today, our leading candidates include gene therapy treatments in the fields of Rheumatology / Osteoarthritis, Endocrinology / Diabetes, and Neurology / Stroke.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.3M
- Last round: Corporate Round (Sep 2025)
- Website: remedium-bio.com
- Phone: +1 (978) 467 5217
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/remedium-bio-9067 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.